These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 23615769)

  • 1. Von Willebrand factor antigen predicts response to double dose of aspirin and clopidogrel by PFA-100 in patients undergoing primary angioplasty for ST elevation myocardial infarction.
    Gianetti J; Parri MS; Della Pina F; Marchi F; Koni E; De Caterina A; Maffei S; Berti S
    ScientificWorldJournal; 2013; 2013():313492. PubMed ID: 24453831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI).
    Sukmawan R; Hoetama E; Suridanda Danny S; Giantini A; Listiyaningsih E; Gilang Rejeki V; Aziz Alkatiri A; Firdaus I
    Pharmacol Res Perspect; 2021 Apr; 9(2):e00738. PubMed ID: 33641235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of age on pre-procedural TIMI flow in STEMI patients undergoing primary percutaneous coronary intervention.
    Verdoia M; Gioscia R; Viola O; Brancati MF; Soldà PL; Rognoni A; De Luca G;
    J Cardiovasc Med (Hagerstown); 2023 Sep; 24(9):631-636. PubMed ID: 37605955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet Therapy, Pretreatment, and Primary PCI: Every Minute Counts.
    Silvain J; Montalescot G; Guedeney P
    J Am Coll Cardiol; 2024 Jun; 83(25):2640-2642. PubMed ID: 38897673
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiplatelet efficacy of ticagrelor versus clopidogrel in Mediterranean patients with diabetes mellitus and chronic coronary syndromes: A crossover pharmacodynamic investigation.
    Marcano AL; Gracida M; Roura G; Gomez-Lara J; Romaguera R; Teruel L; Fuentes L; Muntané-Carol G; Meroño O; Sosa SG; Gómez-Hospital JA; Comin-Colet J; Ferreiro JL
    Front Cardiovasc Med; 2022; 9():1057331. PubMed ID: 36483622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet inhibition to target reperfusion injury trial: Rationale and study design.
    Bulluck H; Chan MHH; Bryant JA; Chai P; Chawla A; Chua TS; Chung YC; Fei G; Ho HH; Ho AFW; Hoe AJ; Imran SS; Lee CH; Lim SH; Liew BW; Yun PLZ; Hock MOE; Paradies V; Roe MT; Teo L; Wong AS; Wong E; Wong PE; Watson T; Chan MY; Tan JW; Hausenloy DJ
    Clin Cardiol; 2019 Jan; 42(1):5-12. PubMed ID: 30421441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of New Antiplatelet Drugs on Cardiovascular Disease: Update on Cangrelor.
    Marcano AL; Ferreiro JL
    Curr Atheroscler Rep; 2016 Nov; 18(11):66. PubMed ID: 27714642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of mild hypothermia on platelet responsiveness to aspirin and clopidogrel: an in vitro pharmacodynamic investigation.
    Ferreiro JL; Sánchez-Salado JC; Gracida M; Marcano AL; Roura G; Ariza A; Gómez-Lara J; Lorente V; Romaguera R; Homs S; Sánchez-Elvira G; Teruel L; Rivera K; Sosa SG; Gómez-Hospital JA; Angiolillo DJ; Cequier A
    J Cardiovasc Transl Res; 2014 Feb; 7(1):39-46. PubMed ID: 24362676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis appraising high maintenance dose clopidogrel in patients who underwent percutaneous coronary intervention with and without high on-clopidogrel platelet reactivity.
    Ma W; Liang Y; Zhu J; Wang Y; Wang X
    Am J Cardiol; 2015 Mar; 115(5):592-601. PubMed ID: 25613665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clopidogrel pretreatment in primary percutaneous coronary intervention: prevalence of high on-treatment platelet reactivity and impact on preprocedural patency of the infarct-related artery.
    Ferreiro JL; Homs S; Berdejo J; Roura G; Gómez-Lara J; Romaguera R; Teruel L; Sánchez-Elvira G; Marcano AL; Gómez-Hospital JA; Angiolillo DJ; Cequier Á
    Thromb Haemost; 2013 Jul; 110(1):110-7. PubMed ID: 23615769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind, randomized, prospective comparison of loading doses of 600 mg clopidogrel versus 60 mg prasugrel in patients with acute ST-segment elevation myocardial infarction scheduled for primary percutaneous intervention: the ETAMI trial (early thienopyridine treatment to improve primary PCI in patients with acute myocardial infarction).
    Zeymer U; Mochmann HC; Mark B; Arntz HR; Thiele H; Diller F; Montalescot G; Zahn R
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):147-154. PubMed ID: 25616919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High post-clopidogrel platelet reactivity assessed by a point-of-care assay predicts long-term clinical outcomes in patients with ST-segment elevation myocardial infarction who underwent primary coronary stenting.
    Jin HY; Yang TH; Kim DI; Chung SR; Seo JS; Jang JS; Kim DK; Kim DK; Kim KH; Seol SH; Nam CW; Hur SH; Kim W; Park JS; Kim YJ; Kim DS
    Int J Cardiol; 2013 Sep; 167(5):1877-81. PubMed ID: 22682702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clopidogrel pretreatment of patients with ST-elevation myocardial infarction does not affect platelet reactivity after subsequent prasugrel-loading: platelet reactivity in an observational study.
    Nührenberg TG; Trenk D; Leggewie S; Ristau I; Amann M; Stratz C; Hochholzer W; Valina CM; Neumann FJ
    Platelets; 2013; 24(7):549-53. PubMed ID: 23216528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of platelet and inflammatory system activation on outcomes in diabetic patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Kuliczkowski W; Greif M; Gąsior M; Kaczmarski J; Pres D; Poloński L
    Kardiol Pol; 2011; 69(6):531-7. PubMed ID: 21678284
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.